🔬 Pharmidex at "From Innovation to Adoption in Gene Therapies"! 🚀
February 27, 2025

We’re excited to announce that Radhakrishnan Venkatasamy, our Principal Research Scientist specializing in autoimmune diseases, will be attending From Innovation to Adoption in Gene Therapies, hosted by One Nucleus on Thursday, 27 February 2025 at Level 39, Canary Wharf, London.


This event brings together experts to explore the latest advancements in gene therapies, and Radhakrishnan is eager to connect with fellow innovators to discuss new opportunities for collaboration. 

Let’s work together to accelerate drug discovery and development!


📍 Event details:

📅 Date: Thursday, 27 February 2025

⏰ Time: 15:00 – 19:30

📍 Location: Level 39, One Canada Square, Canary Wharf, London E14 5AB

🔗 More info: (https://lnkd.in/efEUWfCJ)

💬 Interested in partnering with Pharmidex? Connect with Radhakrishnan at the event or reach out to us!

#GeneTherapy #Pharmidex #DrugDiscovery #BiotechInnovation #Collaboration


March 16, 2026
Pharmidex is proud to be the Networking Sponsor at the Immuno-Oncology & Biomarker Summit in London. Over the next two days, the event provides an opportunity to discuss the latest advances in immuno-oncology, biomarker discovery, and precision medicine. If you’re attending, come and say hello to Ash Alavijeh to connect and explore opportunities to collaborate.
March 13, 2026
We’re excited to announce that Janette Dalay Robertson , Business Development Manager at Pharmidex , will be attending and exhibiting at the 10th RSC-BMCS Symposium on Mastering Medicinal Chemistry on Friday 13 March 2026 at Burlington House, London. Pharmidex is also proud to be sponsoring this fantastic event, which brings together leaders and innovators from across the medicinal chemistry community. If you’re attending, make sure to stop by and speak with Janette at the Pharmidex stand. She will be delighted to connect, discuss your research, and explore how Pharmidex can support your drug discovery and development programmes. 🤝 We look forward to meeting fellow scientists, collaborators, and partners at this exciting meeting.
March 9, 2026
We are pleased to share that Janette Dalay Robertson will be attending Cell & Gene Therapy 2026 taking place 9–10 March 2026 at Hinxton Hall Conference Centre, Cambridge. This event is a fantastic opportunity to connect with leaders across the cell and gene therapy ecosystem and Janette will be there representing Pharmidex and discussing how our scientific services support drug discovery and development. 🤝 Janette would be delighted to meet with fellow attendees to: • Explore new collaborations • Discuss upcoming research programs • Share how Pharmidex can support innovative therapeutic development If you are attending, feel free to reach out and arrange a meeting during the event. We look forward to engaging conversations and building new partnerships within the cell and gene therapy community!
More Posts